Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Following the discovery of exendin-4, pharmaceutical companies recognised the therapeutic potential and began developing synthetic versions of this peptide for human use
Elevated L-tryptophan levels have been observed in fibrotic models and are positively associated with pro-inflammatory cytokines [112]
in TCC, GSTP1 should be considered as a potential therapeutic target This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 183,71 per year only 15,31 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Its pathogenesis involves multifactorial mechanisms and exhibits significant variability in disease progression among individuals
US$ 25.48
US$ 29.09
US$ 23.56
US$ 22.02
US$ 29.49
US$ 29.33
US$ 20.15
